Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Non Operating Income (2016 - 2025)

Prestige Consumer Healthcare has reported Non Operating Income over the past 16 years, most recently at -$10.0 million for Q4 2025.

  • Quarterly results put Non Operating Income at -$10.0 million for Q4 2025, down 2734.28% from a year ago — trailing twelve months through Dec 2025 was -$24.0 million (up 74.27% YoY), and the annual figure for FY2025 was -$5.0 million, up 92.54%.
  • Non Operating Income for Q4 2025 was -$10.0 million at Prestige Consumer Healthcare, up from -$10.5 million in the prior quarter.
  • Over the last five years, Non Operating Income for PBH hit a ceiling of $49.9 million in Q1 2022 and a floor of -$68.7 million in Q1 2023.
  • Median Non Operating Income over the past 5 years was -$11.6 million (2024), compared with a mean of -$12.7 million.
  • Peak annual rise in Non Operating Income hit 263.42% in 2022, while the deepest fall reached 15449.52% in 2022.
  • Prestige Consumer Healthcare's Non Operating Income stood at -$17.1 million in 2021, then fell by 11.5% to -$19.1 million in 2022, then soared by 96.42% to -$682000.0 in 2023, then skyrocketed by 48.24% to -$353000.0 in 2024, then tumbled by 2734.28% to -$10.0 million in 2025.
  • The last three reported values for Non Operating Income were -$10.0 million (Q4 2025), -$10.5 million (Q3 2025), and $224000.0 (Q2 2025) per Business Quant data.